Effects of soy isoflavones on menopausal symptoms in perimenopausal women: a systematic review and meta-analysis
PeerJ · 23.07.2025 · 13 · e19715
DOI: 10.7717/peerj.19715 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift PeerJ, online erschienen am 23.07.2025. Verfasst von Haodi Luan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Nutrition Department, Critical Care Medicine Department, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China. Hauptthemen laut MEDLINE: Isoflavones, Perimenopause, Glycine max, Menopause. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Innovation and Entrepreneurship Project of Inner Mongolia Medical University of China, The Inner Mongolia Medical University Innovation Team Project, The Inner Mongolia Medical University Youth Project.
Abstract (Originalsprache)
Soy isoflavones are phytoestrogens found mainly in soy and its derivatives. Given their estrogen-like and antioxidant-inhibiting inflammatory effects, they have been hypothesized to be effective in treating menopausal symptoms. We conducted a systematic review in accordance with the PRISMA guidelines. In October 2024, we screened 2,099 articles, of which 12 were eligible for meta-analysis, and found that soy isoflavones were effective for treating menopausal symptoms (seven studies, 533 participants, Hedges’ g = −0.25, 95% CI [−0.42 to −0.08], p = 0.00). Soy isoflavones showed significant effects on headache (three studies, 340 participants, Hedges’ g = −0.38, 95% CI [−0.60 to −0.17], p = 0.00), psychosocial symptoms (five studies, 416 participants, Hedges’ g = −0.29, 95% CI [−0.48 to −0.10], p = 0.00), palpitation (three studies, 356 participants, Hedges’ g = −0.42, 95% CI [−0.63 to −0.22], p = 0.00), and depression (four studies, 748 participants, Hedges’ g = −0.72, 95% CI [−1.17 to −0.28], p = 0.00), but no significant treatment effect on paresthesia symptoms, fatigue symptoms, physical symptoms, hot flushes, excessive sweating, insomnia, and vasomotor symptoms was observed. However, our results should be interpreted with caution owing to the small sample size. More trials should be conducted in the future to validate our findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Nutrition Department, Critical Care Medicine Department, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
- Department of Gastroenterology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
- Medical Simulation Center, Inner Mongolia Medical University, Hohhot, China.
Förderung
- The Innovation and Entrepreneurship Project of Inner Mongolia Medical University of China
- The Inner Mongolia Medical University Innovation Team Project
- The Inner Mongolia Medical University Youth Project
- The Natural Science Key Project of Higher Education Research in Inner Mongolia Autonomous Region
Zitieren
APA
Luan, H., Liu, Q., Guo, Y., Fan, H., A, S., & Lin, J. (2025). Effects of soy isoflavones on menopausal symptoms in perimenopausal women: a systematic review and meta-analysis. PeerJ, 13, e19715. https://doi.org/10.7717/peerj.19715
Vancouver
Luan H, Liu Q, Guo Y, Fan H, A S, Lin J. Effects of soy isoflavones on menopausal symptoms in perimenopausal women: a systematic review and meta-analysis. PeerJ. 2025;13:e19715. doi:10.7717/peerj.19715
BibTeX
@article{Luan2025,
author = {Luan, Haodi and Liu, Qianqian and Guo, Yahui and Fan, Hua and A, Sileng and Lin, Jing},
title = {Effects of soy isoflavones on menopausal symptoms in perimenopausal women: a systematic review and meta-analysis},
journal = {PeerJ},
year = {2025},
volume = {13},
pages = {e19715},
doi = {10.7717/peerj.19715}
}
EUVIMED